Harshad S Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 W. Kern Avenue, Mcfarland, CA 93250 Phone: 661-792-2198 |
News Archive
SciDev.Net examines tuberculosis (TB) in India, which has the world's highest TB burden, and some experts' hopes that researchers in the country can develop accurate and affordable diagnostic test kits.
Without following a particular diet, overweight people who tracked daily food consumption using a free smartphone app lost a significant amount of weight in a new Duke University study.
Glenmark Pharmaceuticals today announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
› Verified 3 days ago